Material Safety Data Sheet
Cadmium chloride hemipentahydrate
ACC# 03745
Section 1 - Chemical Product and Company Identification |
MSDS Name: Cadmium chloride hemipentahydrate
Catalog Numbers:
AC197020000, AC197020250, AC197022500, AC423500000, AC423505000, C9-100,
C9-500, S75062, S75063
Synonyms:
Cadmium dichloride, hydrate (2:5).
Company Identification:
Fisher Scientific
1 Reagent Lane
Fair Lawn, NJ 07410
For information, call: 201-796-7100
Emergency Number: 201-796-7100
For CHEMTREC assistance, call: 800-424-9300
For International CHEMTREC assistance, call: 703-527-3887
Section 2 - Composition, Information on Ingredients
|
CAS# |
Chemical Name |
Percent |
EINECS/ELINCS |
7790-78-5 |
Cadmium chloride hemipentahydrate |
100 | unlisted |
Section 3 - Hazards Identification
|
EMERGENCY OVERVIEW
Appearance: white crystals.
Danger! Can cause lung and kidney disease. May be
fatal if inhaled. Cancer hazard. Harmful if swallowed. May cause
harm to the unborn child. May impair fertility. Avoid creating dust.
May cause eye, skin, and respiratory tract irritation. Contains
cadmium. Hygroscopic (absorbs moisture from the air). Severe marine
pollutant.
Target Organs: Blood, kidneys, liver, lungs,
respiratory system, skeletal structures, prostate, reproductive
system.
Potential Health Effects
Eye:
May cause eye irritation. Exposure to the substance as an aqueous
solution may cause irritation and corneal abnormalities.
Skin:
May cause skin irritation. May be absorbed through the skin in
harmful amounts.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. Exposure may cause severe swelling of face and neck areas
with possible death.
Inhalation:
May be fatal if inhaled. Irritation may lead to chemical pneumonitis
and pulmonary edema. May cause ulceration and perforation of the
nasal septum if inhaled in excessive quantities.
Chronic:
May cause respiratory tract cancer. Prolonged or repeated exposure
may cause permanent bone structure abnormalities. Chronic inhalation
may cause nasal septum ulceration and perforation. Chronic
inhalation of cadmium compounds has been associated with lung and
prostate cancer. The primary target organ for chronic cadmium disease
is clearly the kidney. An inhalation study of cadmium chloride in
rats exposed 23 hrs/day for 18 mo at 12.5, 25 or 50 ug/m3, as Cd,
produced a frequency of primary lung carcinomas of 15.4%, 52.6% and
71.4%, respectively. There were no primary lung carcinomas in the
controls.
Section 4 - First Aid Measures
|
Eyes:
In case of contact, immediately flush eyes with plenty of water for a
t least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
POISON material. If inhaled, get medical aid immediately. Remove
victim to fresh air. If not breathing, give artificial respiration.
If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.
Antidote:
The use of Calcium disodium EDTA as a chelating agent should be
determined by qualified medical personnel.
Section 5 - Fire Fighting Measures
|
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Water runoff can cause environmental damage. Dike
and collect water used to fight fire. Non-combustible, substance
itself does not burn but may decompose upon heating to produce
corrosive and/or toxic fumes.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Flash Point: Not applicable.
Autoignition Temperature: Not applicable.
Explosion Limits, Lower:Not available.
Upper: Not available.
NFPA Rating:
(estimated) Health: 4; Flammability: 0; Instability: 0
Section 6 - Accidental Release Measures
|
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid runoff into storm sewers and ditches which lead to
waterways. Clean up spills immediately, observing precautions in the
Protective Equipment section. Wear a self contained breathing
apparatus and appropriate personal protection. (See Exposure
Controls, Personal Protection section). Avoid generating dusty
conditions. Provide ventilation.
Section 7 - Handling and Storage
|
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Do not
get in eyes, on skin, or on clothing. Do not breathe dust. Use only
with adequate ventilation.
Storage:
Do not store in direct sunlight. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
Section 8 - Exposure Controls, Personal Protection
|
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits. Facilities storing or utilizing this material should
be equipped with an eyewash facility and a safety shower. Use
substance with extreme caution and designate regulated areas for use.
See 29CFR 1910.1027 for regulations applying to all occupational
exposures to cadmium and cadmium compounds, in all forms.
Exposure Limits
Chemical Name |
ACGIH |
NIOSH |
OSHA - Final PELs |
Cadmium chloride hemipentahydrate
|
0.01 mg/m3 TWA (as Cd); 0.002 mg/m3 TWA (respirable fraction, as Cd) (listed under Cadmium compounds).
|
none listed
|
2.5 æg/m3 Action Level (as Cd); 5 æg/m3 PEL (as Cd. Do not eat, drink or chew t obacco or gum or apply cosmetics in regulated areas. Carcinogen: dust can cause lung and kidney disease. See 29 CFR
1910.1027) (listed under Cadmium compounds).
|
Cadmium chloride anhydrous
|
0.01 mg/m3 TWA (as Cd); 0.002 mg/m3 TWA (respirable fraction, as Cd) (listed under Cadmium compounds).
|
none listed
|
2.5 æg/m3 Action Level (as Cd); 5 æg/m3 PEL (as Cd. Do not eat, drink or chew t obacco or gum or apply cosmetics in regulated areas. Carcinogen: dust can cause lung and kidney disease. See 29 CFR
1910.1027) (listed under Cadmium compounds).
|
OSHA Vacated PELs:
Cadmium chloride hemipentahydrate:
No OSHA Vacated PELs are listed for this chemical.
Cadmium chloride anhydrous:
No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear impervious gloves.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
Section 9 - Physical and Chemical Properties
|
Physical State: Crystals
Appearance: white
Odor: odorless
pH: Not available.
Vapor Pressure: 10 mm Hg @ 656 deg C
Vapor Density: Not available.
Evaporation Rate:Not available.
Viscosity: Not available.
Boiling Point: 960 deg C @ 760 mm Hg
Freezing/Melting Point:568 deg C
Decomposition Temperature:Not available.
Solubility: Freely Soluble.
Specific Gravity/Density:3.33 g/cm3 @ 25°C
Molecular Formula:CdCl2.2.5H2O
Molecular Weight:228.34
Section 10 - Stability and Reactivity
|
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. Readily effloresces (loses water molecules
of hydration) on exposure to air, leaving a powdery coating on the
material.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, bromine trifluoride, sulfur, potassium,
selenium, tellurium, hydrogen azide.
Hazardous Decomposition Products:
Cadmium fumes, chloride fumes, toxic cadmium oxide fumes.
Hazardous Polymerization: Will not occur.
Section 11 - Toxicological Information
|
RTECS#:
CAS# 7790-78-5:
EV0178000
CAS# 10108-64-2:
EV0175000
LD50/LC50:
CAS# 7790-78-5:
Oral, mouse: LD50
= 194 mg/kg;
Oral, rat: LD50 = 665
mg/kg;
.
CAS# 10108-64-2:
Oral, mouse:
LD50 = 60 mg/kg;
Oral, mouse: LD50
= 3.3 mg/kg;
Oral, rat: LD50 = 88
mg/kg;
.
Skin, guinea pig: LDLo = 233 mg/kg.
ation, dog: LC90 = 420
mg/m3/30M.
Carcinogenicity:
CAS# 7790-78-5:
- ACGIH:
A2 - Suspected Human Carcinogen (listed as 'Cadmium compounds').
- California:
carcinogen, initial date 10/1/87 (listed as Cadmium compounds).
- NTP:
Known carcinogen (listed as Cadmium compounds).
- IARC:
Group 1 carcinogen (listed as Cadmium compounds).
CAS# 10108-64-2:
- ACGIH:
A2 - Suspected Human Carcinogen (listed as 'Cadmium compounds').
- California:
carcinogen, initial date 10/1/87 (listed as Cadmium compounds).
- NTP:
Known carcinogen (listed as Cadmium compounds).
- IARC:
Group 1 carcinogen (listed as Cadmium compounds).
Epidemiology:
Studies suggest that occupational inhalation of cadmium is
correlated with an increased lung cancer risk. Please
refer to Patty's Industrial Hygiene and Toxicology and
IARC volume 11 for a more detailed discussion.
Teratogenicity:
Cadmium has been shown to be teratogenic or embryotoxic in
several animal species, causing a variety of major
malformations, including defects of the brain, face, lungs,
limbs, and abdominal viscera. In some models (such as the
rat), cadmium showsprominent toxicity for the placenta, and
cadmium has been associated with fetal growth retardation
in this animal. In vitro studies suggest that cadmium is
likely to be toxic to the human placenta.
Reproductive Effects:
A number of animal experiments have investigated the
toxicity of cadmium on male reproductive function. In high
doses and after chronic administration, Cd produces
vascular changes and ischemic (affected with deficiency of
blood) necrosis in the testes.Single low dose studies have
indicated that Cd can have selective effects on sperm
formation, impairing the release of sperm from the
seminiferous epithelium in the rat. Also, at low doses
that don't interfere with testicular function, Cd exposure
in ratshas been associated with an increased incidence of
prostate tumors. Reports on testicular & endocrine
function in men occupationally exposed to Cd are quite
limited, & no clearly identified testicular toxicity has
been demonstrated in these workers.
Mutagenicity:
DNA Damage: hamster embryo 2 umol/L, mammal lymphocyte 350
umol/L. DNA Inhibition: hamster lung and mammal kidney 2
umol/L. Unscheduled DNA Synthesis: hamster embryo 10
umol/L. Gene Mutation in Mammal Cells: hamster lung 1
umol/L.
Neurotoxicity:
No information available.
Other Studies:
Section 12 - Ecological Information
|
Ecotoxicity:
Fish: Bluegill/Sunfish: 1.94ppm; 96H;
Japanese quail, oral LC50=2584 ppm/5D Ring-necked pheasant, oral
LC50=767 ppm/5D
Environmental:
Substance is mobile in water (movement as hydrated cations or as
complexes). Absorption (soil) is dependent on pH with increasing
values for alkaline conditions. Cadmium chloride is expected to
significantly bioaccumulate. CdCl2 bioconcentrates in fish and
aquatic organisms.
Physical:
No information available.
Other:
No information available.
Section 13 - Disposal Considerations
|
Chemical waste generators must determine whether a discarded chemical is classified
as a hazardous waste.
US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3.
Additionally, waste generators must consult state and local hazardous waste regulations to
ensure complete and accurate classification.
RCRA P-Series: None listed.
RCRA U-Series: None listed.
Section 14 - Transport Information
|
|
US DOT |
Canada TDG |
Shipping Name: |
CADMIUM COMPOUNDS |
Cadmium Compounds |
Hazard Class: |
6.1 |
6.1 |
UN Number: |
UN2570 |
UN2570 |
Packing Group: |
III |
III |
Section 15 - Regulatory Information
|
US FEDERAL
TSCA
CAS# 7790-78-5 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 10108-64-2 is listed on the TSCA inventory.
Health & Safety Reporting List
None of the chemicals are on the Health & Safety Reporting List.
Chemical Test Rules
None of the chemicals in this product are under a Chemical Test Rule.
Section 12b
None of the chemicals are listed under TSCA Section 12b.
TSCA Significant New Use Rule
None of the chemicals in this material have a SNUR under TSCA.
CERCLA Hazardous Substances and corresponding RQs
CAS# 10108-64-2: 10 lb final RQ; 4.54 kg final RQ
SARA Section 302 Extremely Hazardous Substances
None of the chemicals in this product have a TPQ.
SARA Codes
CAS # 7790-78-5: immediate, delayed.
CAS # 10108-64-2: immediate, delayed.
Section 313
This material contains Cadmium
chloride hemipentahydrate (listed as Cadmium compounds), 100%, (CAS#
7790-78-5) which is subject to the reporting requirements of Section
313 of SARA Title III and 40 CFR Part 373.
This material contains Cadmium
chloride anhydrous (listed as Cadmium compounds), -%, (CAS#
10108-64-2) which is subject to the reporting requirements of
Section 313 of SARA Title III and 40 CFR Part 373.
Clean Air Act:
CAS# 7790-78-5 (listed as Cadmium compounds) is listed as a hazardous
air pollutant (HAP).
CAS# 10108-64-2 (listed as Cadmium compounds) is listed as a hazardous
air pollutant (HAP).
This material does not contain any Class 1 Ozone depletors.
This material does not contain any Class 2 Ozone depletors.
Clean Water Act:
CAS# 10108-64-2 is listed as a Hazardous Substance under the CWA.
None of the chemicals in this
product are listed as Priority Pollutants under the CWA.
CAS# 7790-78-5 is listed as a Toxic Pollutant under the Clean Water
Act.
CAS# 10108-64-2 is listed as a Toxic Pollutant under the Clean Water
Act.
OSHA:
None of the chemicals in this product
are considered highly hazardous by OSHA.
STATE
CAS# 7790-78-5 can be found on the
following state right to know lists: California, (listed as Cadmium
compounds), Pennsylvania, (listed as Cadmium compounds), Minnesota,
(listed as Cadmium compounds).
CAS# 10108-64-2 can be found on the
following state right to know lists: California, New Jersey,
Pennsylvania, Minnesota, (listed as Cadmium compounds),
Massachusetts.
California Prop 65
The following statement(s) is(are) made in order to comply with
the California Safe Drinking Water Act:
WARNING: This product contains Cadmium chloride hemipentahydrate,
listed as `Cadmium compounds', a chemical known to the state of
California to cause cancer.
WARNING: This product contains Cadmium chloride anhydrous, listed as
`Cadmium compounds', a chemical known to the state of California to
cause cancer.
California No Significant Risk Level:
None of the chemicals in this product are listed.
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols:
T+ N
Risk Phrases:
R 25 Toxic if swallowed.
R 26 Very toxic by inhalation.
R 45 May cause cancer.
R 46 May cause heritable genetic damage.
R 48/23/25 Toxic : danger of serious damage to health by prolonged
exposure through inhalation and if swallowed.
R 60 May impair fertility.
R 61 May cause harm to the unborn child.
R 50/53 Very toxic to aquatic organisms, may cause long-term
adverse effects in the aquatic environment.
Safety Phrases:
S 45 In case of accident or if you feel unwell, seek medical advice
immediately (show the label where possible).
S 53 Avoid exposure - obtain special instructions before use.
S 60 This material and its container must be disposed of as hazardou
s waste.
S 61 Avoid release to the environment. Refer to special instructions
/safety data sheets.
WGK (Water Danger/Protection)
CAS# 7790-78-5: No information available.
CAS# 10108-64-2: No information available.
Canada - DSL/NDSL
CAS# 10108-64-2 is listed on Canada's DSL List.
Canada - WHMIS
This product has a WHMIS classification of D1A, D2A.
This product has been classified in accordance with the hazard
criteria of the Controlled Products Regulations and the MSDS
contains all of the information required by those regulations.
Canadian Ingredient Disclosure List
CAS# 7790-78-5 (listed as Cadmium compounds) is listed on the Canadian Ingredient Disclosure List.
CAS# 10108-64-2 is listed on the Canadian Ingredient Disclosure List.
Section 16 - Additional Information
|
MSDS Creation Date: 9/02/1997
Revision #4 Date: 4/24/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall Fisher be liable
for any claims, losses, or damages of any third party or for lost profits
or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if Fisher has been advised of
the possibility of such damages.